Long-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): An evidence-based analysis

Ontario Health Technology Assessment Series

Volumn 12, Issue 7, 2012, Pages 1-64

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ACUTE RESPIRATORY FAILURE; ARTICLE; ATMOSPHERIC PRESSURE; BLOOD OXYGEN TENSION; CAREGIVER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; CHRONIC RESPIRATORY QUESTIONNAIRE; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; ECONOMIC EVALUATION; EVIDENCE BASED MEDICINE; EXERCISE TOLERANCE; FLOW RATE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART FAILURE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPOXEMIA; LONG TERM CARE; LUNG FUNCTION; LUNG VASCULAR RESISTANCE; MASK; MEDICAL ETHICS; META ANALYSIS (TOPIC); MORTALITY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; OXIMETRY; OXYGEN BLOOD LEVEL; OXYGEN DELIVERY DEVICE; OXYGEN NASAL CANNULA; OXYGEN THERAPY; PATIENT SAFETY; PHASE 3 CLINICAL TRIAL (TOPIC); POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PULMONARY REHABILITATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; SMOKING CESSATION; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SURVIVAL RATE; SURVIVOR; SYSTEMATIC REVIEW; TELEMEDICINE; TELEMONITORING; TREATMENT DURATION; VACCINATION; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST BENEFIT ANALYSIS; ECONOMICS; METHODOLOGY; REVIEW;

COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; HUMANS; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84878813304     PISSN: 19157398     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Public Health Agency of Canada. Chronic Obstructive Pulmonary Disease (COPD) [Internet]. [updated 2008 Oct 7; cited 2010 Oct 27]. Available from: http://www.phac-aspc.gc.ca/cd-mc/crdmrc/copd-mpoc-eng.php
2. Corrado A, Renda T, Bertini S. Long-term oxygen therapy in COPD: evidences and open questions of current indications. Monaldi Arch Chest Dis. 2010;73(1):34-43.
3. Global Initiative for Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Obstructive Pulmonary Disease [Internet]. Unknown: Medical Communications Resources Inc. 2009 Jan 1 [cited: 2010 Oct 27]. 109 p. Available from: http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=2003
4. McGloin S. Administration of oxygen therapy. Nurs Stand. 2008;22(21):46-8.
5. Henderson Y. Delivering oxygen therapy to acutely breathless adults. Nurs Stand. 2008;22(35):46-8.
6. Lynes D, Kelly C. Domiciliary oxygen therapy: assessment and management. Nurs Stand. 2009;23(20):50-6.
7. Dunne PJ. The clinical impact of new long-term oxygen therapy technology. Respir Care. 2009;54(8):1100-11.
8. Uronis H, McCrory DC, Samsa G, Currow D, Abernethy A. Palliative oxygen for nonhypoxaemic chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CDD006429. DOI: 10.1002/14651858.CD006429. 2007
9. Osthoff M, Leuppi JD. Management of chronic obstructive pulmonary disease patients after hospitalization for acute exacerbation. Respiration. 2010;79(3):255-61.
10. Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet. 1981;1(8222):681-6.
11. Stark RD, Finnegan P, Bishop JM. Long-term domiciliary oxygen in chronic bronchitis with pulmonary hypertension. Br Med J. 1973;3(5878):467-70.
12. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med. 1980;93(3):391-8.
13. Stoller JK, Panos RJ, Krachman S, Doherty DE, Make B. Oxygen therapy for patients with COPD: Current evidence and the long-term oxygen treatment trial. Chest. 2010;138(1):179-87.
14. O'Donnell DE, Hernandez P, Kaplan A, Aaron S, Bourbeau J, Marciniuk D, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease -2008 update - Highlights for primary care. Can Respir J. 2008;15(SUPPL. A):1A-8A.
15. Ministry of Health and Long-Term Care. Home Oxygen Program - Physician [Internet]. [Toronto, ON]: Government of Ontario. 2004 Jul 1 [cited: 2010 Oct 28]. 3 p. Available from: http://www.health.gov.on.ca/english/public/pub/adp/pdf/oxyphys.pdf
16. Ministry of Health and Long-Term Care. Home Oxygen Program Policy and Administration Manual [Internet]. [Toronto, ON]: Government of Ontario. 2011 May 1 [cited: 2011 Nov 7]. 54 p. Available from: http://www.health.gov.on.ca/en/pro/programs/adp/information_technology/docs/home_oxygen_manual.pdf
17. Canadian Lung Association. Fact sheet: What you need to know about oxygen [Internet]. Ottawa: Canadian Lung Association. 2005 Aug 1 [cited: 2010 Oct 28]. 6 p. Available from: http://www.lung.ca/_resources/Oxygen_COPD_LungAssoc.pdf
18. Make B, Krachman S, Panos RJ, Doherty DE, Stoller JK. Oxygen therapy in advanced COPD: In whom does it work? Semin Respir Crit Care Med. 2010;31(3):334-42.
19. Brinkerhoff S. Oxygen therapy in the home: safety precautions and implications for home healthcare clinicians. Home Healthc Nurse. 2009;27(7):417-20.
20. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490.
21. Goodman, C. Literature searching and evidence interpretation for assessing health care practices. Stockholm, Sweden: Swedish Council on Technology Assessment in Health Care. 1996. 81p. SBU Report No. 119E.
22. United States National Institutes of Health. Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease (The Long-term Oxygen Treatment Trial [LOTT]) [Internet]. [updated 2010 Sep 14; cited 2010 Oct 28]. Available from: http://clinicaltrials.gov/ct2/show/NCT00692198?term=oxygen+therapy&rank=6
23. Cranston JM, Crockett A, Moss J, Alpers JH. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD001744. DOI: 10.1002/14651858.CD001744.pub2.
24. Gorecka D, Gorzelak K, Sliwinski P, Tobiasz M, Zielinski J. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax. 1997;52(8):674-9.
25. Haidl P, Clement C, Wiese C, Dellweg D, Kohler D. Long-term oxygen therapy stops the natural decline of endurance in COPD patients with reversible hypercapnia. Respiration. 2004;71(4):342-7.
26. Fletcher EC, Luckett RA, Goodnight-White S, Miller CC, Qian W, Costarangos-Galarza C. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. Am Rev Respir Dis. 1992;145(5):1070-6.
27. Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Enrhart M, Schott R, et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J. 1999;14(5):1002-8.
28. Wilt TJ, Niewoehner D, MacDonald R, Kane RL. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. Ann Intern Med. 2007;147(9):639-53.
29. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA. 2003;290(17):2301-12.
30. Eaton T, Fergusson W, Kolbe J, Lewis CA, West T. Short-burst oxygen therapy for COPD patients: a 6-month randomised, controlled study. Eur Respir J. 2006;27(4):697-704.
31. Eaton T, Garrett JE, Young P, Fergusson W, Kolbe J, Rudkin S et al. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J. 2002;20(2):306-12.
32. McDonald CF, Blyth CM, Lazarus MD, Marschner I, Barter CE. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia. Am J Respir Crit Care Med. 1995;152(5 Pt 1):1616-9.
33. Lacasse Y, Lecours R, Pelletier C, Begin R, Maltais F. Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J. 2005;25(6):1032-8.
34. Bahadori K, FitzGerald JM. Risk factors of hospitalization and readmission of patients with COPD exacerbation - Systematic review. Int J Chron Obstruct Pulmon Dis. 2007;2(3):241-51.
35. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58(2):100-5.
36. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(1):158-64.
37. Goksu E, Oktay C, Kartal M, Oskay A, Sayrac AV. Factors affecting revisit of COPD exacerbated patients presenting to emergency department. Eur J Emerg Med. 2010;17(5):283-5.
38. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J. 2007;30(5):993-1013.
39. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of comorbidities. Eur Respir J. 2006;28(6):1245-57.
40. Ekstrom M, Franklin KA, Strom KE. Increased relative mortality in women with severe oxygendependent COPD. Chest. 2010;137(1):31-6.
41. Gross NJ. Chronic obstructive pulmonary disease outcome measurements: what's important? What's useful? Proc Am Thorac Soc. 2005;2(4):267-71.
42. Wedzicha JA. Effects of long-term oxygen therapy on neuropsychiatric function and quality of life. Respir Care. 2000;45(1):119-24.
43. Agence d'evaluation des technologies et des modes d'intervention en sante (AETMIS) (Report prepared by Susan Law and Pascale Lehoux). Hospital Technology at Home: Portable Oxygen Therapy in COPD [Internet]. Montreal: AETMIS. 2004 Jul 1 [cited: 2011 Jan 19]. 103 p. AETMIS 04-03. Available from: http://www.aetmis.gouv.qc.ca/site/download.php?f=2c3728e0d8adac6eb66642754ecbdb9b
44. Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J. Long-term oxygen therapy improves health-related quality of life. Respir Med. 2004;98(4):285-93.
45. Crockett AJ, Cranston JM, Moss JR, Alpers JH. Effects of long-term oxygen therapy on quality of life and survival in chronic airflow limitation. Monaldi Arch Chest Dis. 1999;54(2):193-6.
46. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407-15.
47. Okubadejo AA, Paul EA, Jones PW, Wedzicha JA. Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur Respir J. 1996;9(11):2335-9.
48. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001;56(11):880-7.
49. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932-46.
50. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-55.
51. The National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004;59(Suppl 1):1-232.
52. McDonald CF, Crockett AJ, Young IH. Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand. Med J Aust. 2005;182(12):621-6.